Medication info
Megarojet Tablet 10/10 mg

Megarojet Tablet 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Handok Co., Ltd.
Appearance
Yellow oblong film-coated tablet
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201506792 · Approved 2015.09.24 · Insurance code 652105500

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Handok Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels while raising HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It is used mainly in conjunction with dietary therapy when response to non-drug treatment is insufficient. In addition, various risk factors should be closely considered when administering lipid-lowering medications to patients at high risk for atherosclerotic vascular disease. Before using this medication, secondary causes such as diabetes and hypothyroidism should be confirmed and treated if necessary, and blood lipid levels should be checked regularly during treatment. This management process helps prevent complications arising from hypercholesterolemia and contributes to improving health.

How to take

Adult dose

Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg~10/20mg daily. The recommended initial dose is 10/5mg daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience.

Precautions

This medication can rarely cause damage to muscle tissue, which can lead to severe kidney problems; therefore, if sudden muscle pain or weakness occurs, you should consult a doctor immediately. This medication should not be used if there is an allergy to any of its components or if there are problems with liver or kidney function. Pregnant or breastfeeding women should not take this medication, and women of childbearing age should use adequate contraception during treatment. Patients with liver dysfunction or excessive alcohol consumption should use this medication with caution and should undergo regular liver function tests. Due to the risk of muscle-related side effects, elderly patients or those with a history of muscle disease should adjust the dosage and receive monitoring according to their doctor's instructions. There may be interactions with other medications, so if you are taking other medications, be sure to inform your healthcare provider. If severe skin reactions such as rash, urticaria, or severe itching occur during treatment, stop taking the medication immediately and visit a hospital. There is no specific antidote in case of overdose, so treatment and supportive care according to symptoms are needed, and liver function and muscle enzyme levels should be monitored periodically. Safety and efficacy in children have not been established, so it is not recommended. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, dyspepsia, elevation of ALT, edema, myalgia, elevation of CPK, elevation of AST, headache, acute pyelonephritis, dry mouth, elevation of liver enzymes, abnormal liver function tests, increase in serum lactate dehydrogenase, pruritus, upper respiratory infection, elevated blood glucose, chest discomfort, arthralgia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, cold sweat, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, eyelid ptosis, diabetic retinopathy, ear discomfort, renal impairment, vascular edema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myopathy, myositis, asthenia, polyneuropathy, memory loss, peripheral neuropathy, cough, shortness of breath, diarrhea, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, myasthenia gravis, ocular myasthenia gravis, chest pain, strange sensations, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, orthostatic dizziness, migraine, impaired glucose tolerance, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver disorders, liver toxicity, acute hepatitis, toxic hepatitis, increase in gamma-glutamyl transferase, increase in blood cholesterol, increase in serum alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, cold sweat, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cyst, eyelid ptosis, diabetic retinopathy, ear discomfort, renal impairment, benign esophageal neoplasm, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, constipation, elevation of AST, asthenia, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, anorexia, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, hematuria, urticaria, hyperhidrosis, rash, itching, upper respiratory infection, conjunctival congestion, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is best to keep it at a temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage can help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Yellow oblong film-coated tablet

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.